Authors:
BOURKE T
CARR A
FENNELLY D
MCDERMOTT E
CROWN J
Citation: T. Bourke et al., IMPROVED DOCTOR PATIENT COMMUNICATION INDEXES IN ONCOLOGY - RESULTS OF A PROSPECTIVE, CONTROLLED EVALUATION AND INTERVENTION BASED ON THE E4 MODEL/, Annals of oncology, 9, 1998, pp. 677-677
Authors:
BOYLE JR
MCDERMOTT E
CROWTHER M
WILLS AD
BELL PRF
THOMPSON MM
Citation: Jr. Boyle et al., DOXYCYCLINE INHIBITS ELASTIN DEGRADATION AND REDUCES METALLOPROTEINASE ACTIVITY IN A MODEL OF ANEURYSMAL DISEASE, Journal of vascular surgery, 27(2), 1998, pp. 354-361
Citation: A. Hill et al., HEREDITARY BREAST-CANCER - REPLY TO LETTER PUBLISHED IN PREVIOUS ISSUE (BR J SURG 1998, 85-570-1), British Journal of Surgery, 85(8), 1998, pp. 1157-1157
Authors:
DUFF M
MCGREAL G
WALSH S
HILL A
MCDERMOTT E
OHIGGINS N
Citation: M. Duff et al., PROSPECTIVE ASSESSMENT OF EARLY MORBIDITY FOLLOWING AXILLARY CLEARANCE FOR BREAST-CARCINOMA, British Journal of Surgery, 85, 1998, pp. 48-48
Authors:
MCCARTHY K
MAGUIRE T
MCGREAL G
MCDERMOTT E
OHIGGINS N
DUFFY MJ
Citation: K. Mccarthy et al., HIGH-LEVELS OF TIMP-1 PREDICT POOR OUTCOME IN PATIENTS WITH BREAST-CANCER, British Journal of Cancer, 78, 1998, pp. 66-66
Authors:
REMACLE AG
NOEL A
DUGGAN C
MCDERMOTT E
OHIGGINS N
FOIDART JM
DUFFY MJ
Citation: Ag. Remacle et al., ASSAY OF MATRIX METALLOPROTEINASES TYPE-1, TYPE-2, TYPE-3 AND TYPE-9 IN BREAST-CANCER, British Journal of Cancer, 77(6), 1998, pp. 926-931
Authors:
DUFFY MJ
DUGGAN C
MAGUIRE T
MCDERMOTT E
OHIGGINS N
Citation: Mj. Duffy et al., CLINICAL-SIGNIFICANCE OF UROKINASE PLASMINOGEN-ACTIVATOR AND ITS RECEPTOR IN BREAST-CANCER, European journal of cancer, 33, 1997, pp. 879-879
Authors:
DUFFY MJ
DUGGAN C
MAGUIRE T
MULCAHY K
ELVIN P
MCDERMOTT E
FENNELLY JJ
OHIGGINS N
Citation: Mj. Duffy et al., UROKINASE PLASMINOGEN-ACTIVATOR AS A PREDICTOR OF AGGRESSIVE DISEASE IN BREAST-CANCER, Enzyme & protein, 49(1-3), 1996, pp. 85-93
Authors:
ODRISCOLL L
KENNEDY S
MCDERMOTT E
KELEHAN P
CLYNES M
Citation: L. Odriscoll et al., MULTIPLE-DRUG RESISTANCE-RELATED MESSENGER-RNA EXPRESSION IN ARCHIVALFORMALIN-FIXED PARAFFIN-EMBEDDED HUMAN BREAST-TUMOR TISSUE, European journal of cancer, 32A(1), 1996, pp. 128-133
Citation: E. Mcdermott et Ma. Khan, FURTHER EVIDENCE FOR GENETIC ANTICIPATION IN FAMILIAL RHEUMATOID-ARTHRITIS, Annals of the Rheumatic Diseases, 55(7), 1996, pp. 475-477
Authors:
DUGGAN C
MAGUIRE T
MCDERMOTT E
OHIGGINS N
FENNELLY JJ
DUFFY MJ
Citation: C. Duggan et al., UROKINASE PLASMINOGEN-ACTIVATOR AND UROKINASE PLASMINOGEN-ACTIVATOR RECEPTOR IN BREAST-CANCER, International journal of cancer, 61(5), 1995, pp. 597-600
Authors:
DUFFY MJ
BLASER J
DUGGAN C
MCDERMOTT E
OHIGGINS N
FENNELLY JJ
TSCHESCHE H
Citation: Mj. Duffy et al., ASSAY OF MATRIX METALLOPROTEASES TYPE-8 AND TYPE-9 BY ELISA IN HUMAN BREAST-CANCER, British Journal of Cancer, 71(5), 1995, pp. 1025-1028
Authors:
DUFFY MJ
REILLY D
MCDERMOTT E
OHIGGINS N
FENNELLY JJ
ANDREASEN PA
Citation: Mj. Duffy et al., UROKINASE PLASMINOGEN-ACTIVATOR AS A PROGNOSTIC MARKER IN DIFFERENT SUBGROUPS OF PATIENTS WITH BREAST-CANCER, Cancer, 74(8), 1994, pp. 2276-2280